OBJECTIVE: Impaired adherence to medication regimens is a serious concern for individuals with schizophrenia linked to relapse and poorer outcomes. One possible reason for poor adherence to medication is poor ability to remember future intentions, labeled prospective memory skills. It has been demonstrated in several studies that individuals with schizophrenia have impairments in prospective memory that are linked to everyday life skills. However, there have been no studies, to our knowledge, examining the relationship of a clinical measure of prospective memory to medication management skills, a key element of successful adherence. METHODS: In this Study 41 individuals with schizophrenia and 25 healthy adults were administered a standardized test battery that included measures of prospective memory, medication management skills, neurocognition, and symptoms. RESULTS: Individuals with schizophrenia demonstrated impairments in prospective memory (both time and event-based) relative to healthy controls. Performance on the test of prospective memory was correlated with the standardized measure of medication management in individuals with schizophrenia. Moreover, the test of prospective memory predicted skills in medication adherence even after measures of neurocognition were accounted for. CONCLUSIONS: This suggests that prospective memory may play a key role in medication management skills and thus should be a target of cognitive remediation programs.
OBJECTIVE: Impaired adherence to medication regimens is a serious concern for individuals with schizophrenia linked to relapse and poorer outcomes. One possible reason for poor adherence to medication is poor ability to remember future intentions, labeled prospective memory skills. It has been demonstrated in several studies that individuals with schizophrenia have impairments in prospective memory that are linked to everyday life skills. However, there have been no studies, to our knowledge, examining the relationship of a clinical measure of prospective memory to medication management skills, a key element of successful adherence. METHODS: In this Study 41 individuals with schizophrenia and 25 healthy adults were administered a standardized test battery that included measures of prospective memory, medication management skills, neurocognition, and symptoms. RESULTS: Individuals with schizophrenia demonstrated impairments in prospective memory (both time and event-based) relative to healthy controls. Performance on the test of prospective memory was correlated with the standardized measure of medication management in individuals with schizophrenia. Moreover, the test of prospective memory predicted skills in medication adherence even after measures of neurocognition were accounted for. CONCLUSIONS: This suggests that prospective memory may play a key role in medication management skills and thus should be a target of cognitive remediation programs.
Authors: Jennifer B Zogg; Steven Paul Woods; Erica Weber; Jennifer E Iudicello; Matthew S Dawson; Igor Grant Journal: Clin Neuropsychol Date: 2010-07-20 Impact factor: 3.535
Authors: Shafali D Jeste; Thomas L Patterson; Barton W Palmer; Christian R Dolder; Sherry Goldman; Dilip V Jeste Journal: Schizophr Res Date: 2003-09-01 Impact factor: 4.939
Authors: Marta Zamroziewicz; Sarah A Raskin; Howard Tennen; Carol S Austad; Rebecca M Wood; Carolyn R Fallahi; Alecia D Dager; Broderick Sawyer; Samantha Leen; Godfrey D Pearlson Journal: Neuropsychology Date: 2016-11-14 Impact factor: 3.295
Authors: Alexandre A Guerin; Yvonne Bonomo; Andrew John Lawrence; Bernhard Theodor Baune; Eric J Nestler; Susan L Rossell; Jee Hyun Kim Journal: Front Psychiatry Date: 2019-12-17 Impact factor: 4.157